LTRN
Lantern Pharma Accelerates into the Golden Age of AI in Medicine
Lantern Pharma, a leading biopharma company, has made significant strides in its operations and business model during the second quarter of 2026. In an exciting development, the company has established Open-Medicine AI as a separate entity to take advantage of the accelerating use of artificial intelligence (AI) in medicine. "